Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
25 Ottobre 2023 - 2:01PM
Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical
company focused on developing and commercializing novel treatments
for gastrointestinal diseases, announced today that members of its
management team are scheduled to participate in the following
investor conferences in November:
Guggenheim Securities 5th
Annual Inflammation, Neurology & Immunology
Conference in New York, NYDate: Tuesday, November 7,
2023Live Webcast: 2:30 p.m. ET Management to participate in
one-on-one meetings throughout the conference
Jefferies London Healthcare Conference in
London, EnglandDate: Tuesday, November 14, 2023Live Webcast: 10:30
a.m. ETManagement to participate in one-on-one meetings throughout
the conference
Stifel 2023 Healthcare
Conference in New York, NYDate: Wednesday, November 15,
2023Live Webcast: 2:25 p.m. ETManagement to participate in
one-on-one meetings throughout the conference
Craig-Hallum 14th
Annual Alpha Select Conference in New York,
NYDate: Thursday, November 16, 2023Management to participate in
one-on-one meetings throughout the conference
Evercore ISI 6th
Annual HealthCONx Conference in Miami, FLDate:
Wednesday, November 29, 2023Live Webcast: 4:15 p.m. ETManagement to
participate in one-on-one meetings throughout the conference
To access the live webcast and archived recordings of each
event, visit the News & Events section of the Phathom website
at
https://investors.phathompharma.com/news-events/events-and-presentations.
Recordings will be available for 90 days following the conclusion
of each meeting.
About Phathom Pharmaceuticals, Inc.Phathom
Pharmaceuticals is a biopharmaceutical company focused on the
development and commercialization of novel treatments for
gastrointestinal diseases. Phathom has in-licensed the exclusive
rights in the United States, Europe, and Canada to vonoprazan, a
first-in-class potassium-competitive acid blocker (PCAB). For more
information about Phathom, visit the Company’s website at
www.phathompharma.com and follow the Company on LinkedIn and
Twitter.
MEDIA CONTACTNick
Benedetto1-877-742-8466media@phathompharma.com
INVESTOR CONTACTEric
Sciorilli1-877-742-8466ir@phathompharma.com
© 2023 Phathom Pharmaceuticals. All rights reserved.
Grafico Azioni Phathom Pharmaceuticals (NASDAQ:PHAT)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Phathom Pharmaceuticals (NASDAQ:PHAT)
Storico
Da Giu 2023 a Giu 2024